Targeting PI4KA sensitizes refractory leukemia to chemotherapy by modulating the ERK/AMPK/OXPHOS axis.

Autor: Xiuxing Jiang, Xiangtao Huang, Guoxun Zheng, Guanfei Jia, Zhiqiang Li, Xin Ding, Ling Lei, Liang Yuan, Shuangnian Xu, Ning Gao
Zdroj: Theranostics; 2022, Vol. 12 Issue 16, p6972-6988, 17p
Databáze: Complementary Index